Recent studies have demonstrated that immunotherapy-activated CD8+ T cells enhance ferroptosis-specific lipid peroxidation in tumor cells and increase the efficacy of cancer immunotherapy [16, 17]. The gene discussed is CD8A; the disease is neoplasm.